Aptevo Therapeutics Reports IXINITY® and Pipeline Progress - Nasdaq

Aptevo Therapeutics Reports IXINITY® and Pipeline Progress  Nasdaq

Reports 73% Increase in IXINITY Year-Over-Year Quarterly Net Revenue in Q1 2019. Anticipates Launching New IXINITY 3,000 IU Assay Mid-2019. Advances ...